October 20th 2025
* Generic lenacapavir could be produced for $25 per person per year at scale, according to an analysis presented at IDWeek 2025 in Atlanta.
Treating MIS-C with intravenous immunoglobulins and methylprednisolone to improve fever course
February 3rd 2021Does using methylprednisolone along with intravenous immunoglobulins improve fever outcomes for multisystem inflammatory syndrome in children (MIS-C) cases? A French investigation offers some answers.
How states addressed issues of equity when schools reopened
December 16th 2020One of the chief concerns with schools being closed was how it would impact children who need certain services or lacked access to basic needs such as food and shelter. A study looks into how state-level guidance addressed these concerns when schools reopened in the fall.
Pfizer COVID-19 vaccine receives emergency use authorization
December 14th 2020Following the green light from the vaccine advisory committee, the US Food and Drug Administration has given emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, making it the first vaccine for COVID-19 approved for use in the United States.